Open Orphan - Business update
ORPH Tue, 04 Feb 2020, 09:00am GMT
Open Orphan was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug focused pharma services company by a management team with extensive industry and financial expertise.
Industry: Health Care
Contact: +353 (01) 6440007
Dublin 2, Ireland
Cathal Friel, Executive Chairman of Open Orphan, provides an update on developments at the company following the successful fundraising, and also introduces Professor John Oxford - a leading expert in the field of virology and an original founder of hVIVO - who will be working with the company as a consultant.